BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 27602994)

  • 21. A novel Salmonella Typhi-based immunotherapy promotes tumor killing via an antitumor Th1-type cellular immune response and neutrophil activation in a mouse model of breast cancer.
    Vendrell A; Gravisaco MJ; Pasetti MF; Croci M; Colombo L; Rodríguez C; Mongini C; Waldner CI
    Vaccine; 2011 Jan; 29(4):728-36. PubMed ID: 21095252
    [TBL] [Abstract][Full Text] [Related]  

  • 22. T helper responses are maintained by basal-like breast cancer cells and confer to immune modulation via upregulation of PD-1 ligands.
    Karasar P; Esendagli G
    Breast Cancer Res Treat; 2014 Jun; 145(3):605-14. PubMed ID: 24816762
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ICOS-ligand expression on plasmacytoid dendritic cells supports breast cancer progression by promoting the accumulation of immunosuppressive CD4+ T cells.
    Faget J; Bendriss-Vermare N; Gobert M; Durand I; Olive D; Biota C; Bachelot T; Treilleux I; Goddard-Leon S; Lavergne E; Chabaud S; Blay JY; Caux C; Ménétrier-Caux C
    Cancer Res; 2012 Dec; 72(23):6130-41. PubMed ID: 23026134
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic Role of Prolactin-Induced Protein (PIP) in Breast Cancer.
    Sauer N; Matkowski I; Bodalska G; Murawski M; Dzięgiel P; Calik J
    Cells; 2023 Sep; 12(18):. PubMed ID: 37759471
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structural study of GCDFP-15/gp17 in disease versus physiological conditions using a proteomic approach.
    Caputo E; Camarca A; Moharram R; Tornatore P; Thatcher B; Guardiola J; Martin BM
    Biochemistry; 2003 May; 42(20):6169-78. PubMed ID: 12755619
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activation of the cholinergic anti-inflammatory system by nicotine attenuates neuroinflammation via suppression of Th1 and Th17 responses.
    Nizri E; Irony-Tur-Sinai M; Lory O; Orr-Urtreger A; Lavi E; Brenner T
    J Immunol; 2009 Nov; 183(10):6681-8. PubMed ID: 19846875
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prolactin inducible protein in cancer, fertility and immunoregulation: structure, function and its clinical implications.
    Hassan MI; Waheed A; Yadav S; Singh TP; Ahmad F
    Cell Mol Life Sci; 2009 Feb; 66(3):447-59. PubMed ID: 18854942
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mammary differentiation induces expression of Tristetraprolin, a tumor suppressor AU-rich mRNA-binding protein.
    Goddio MV; Gattelli A; Slomiansky V; Lacunza E; Gingerich T; Tocci JM; Facchinetti MM; Curino AC; LaMarre J; Abba MC; Kordon EC
    Breast Cancer Res Treat; 2012 Oct; 135(3):749-58. PubMed ID: 22968621
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor cell loaded type-1 polarized dendritic cells induce Th1-mediated tumor immunity.
    Hokey DA; Larregina AT; Erdos G; Watkins SC; Falo LD
    Cancer Res; 2005 Nov; 65(21):10059-67. PubMed ID: 16267032
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Axillary lymph node cellular immune response to HER-2/neu peptides in patients with carcinoma of the breast.
    Kuerer HM; Peoples GE; Sahin AA; Murray JL; Singletary SE; Castilleja A; Hunt KK; Gershenson DM; Ioannides CG
    J Interferon Cytokine Res; 2002 May; 22(5):583-92. PubMed ID: 12060497
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human Mena protein, a serex-defined antigen overexpressed in breast cancer eliciting both humoral and CD8+ T-cell immune response.
    Di Modugno F; Bronzi G; Scanlan MJ; Del Bello D; Cascioli S; Venturo I; Botti C; Nicotra MR; Mottolese M; Natali PG; Santoni A; Jager E; Nisticò P
    Int J Cancer; 2004 May; 109(6):909-18. PubMed ID: 15027125
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interleukin-33/ST2 axis promotes breast cancer growth and metastases by facilitating intratumoral accumulation of immunosuppressive and innate lymphoid cells.
    Jovanovic IP; Pejnovic NN; Radosavljevic GD; Pantic JM; Milovanovic MZ; Arsenijevic NN; Lukic ML
    Int J Cancer; 2014 Apr; 134(7):1669-82. PubMed ID: 24105680
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multiple roles for CD4+ T cells in anti-tumor immune responses.
    Kennedy R; Celis E
    Immunol Rev; 2008 Apr; 222():129-44. PubMed ID: 18363998
    [TBL] [Abstract][Full Text] [Related]  

  • 34. T-helper I immunity, specific for the breast cancer antigen insulin-like growth factor-I receptor (IGF-IR), is associated with increased adiposity.
    Cecil DL; Park KH; Gad E; Childs JS; Higgins DM; Plymate SR; Disis ML
    Breast Cancer Res Treat; 2013 Jun; 139(3):657-65. PubMed ID: 23749321
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IFN-gamma attenuates antigen-induced overall immune response in the airway as a Th1-type immune regulatory cytokine.
    Nakagome K; Okunishi K; Imamura M; Harada H; Matsumoto T; Tanaka R; Miyazaki J; Yamamoto K; Dohi M
    J Immunol; 2009 Jul; 183(1):209-20. PubMed ID: 19542432
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Existent T-cell and antibody immunity to HER-2/neu protein in patients with breast cancer.
    Disis ML; Calenoff E; McLaughlin G; Murphy AE; Chen W; Groner B; Jeschke M; Lydon N; McGlynn E; Livingston RB
    Cancer Res; 1994 Jan; 54(1):16-20. PubMed ID: 7505195
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immune profiles of CD4+ lymphocyte subsets in breast cancer tumor draining lymph nodes.
    Faghih Z; Erfani N; Haghshenas MR; Safaei A; Talei AR; Ghaderi A
    Immunol Lett; 2014; 158(1-2):57-65. PubMed ID: 24326038
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Complement C5a anaphylatoxin is an innate determinant of dendritic cell-induced Th1 immunity to Mycobacterium bovis BCG infection in mice.
    Moulton RA; Mashruwala MA; Smith AK; Lindsey DR; Wetsel RA; Haviland DL; Hunter RL; Jagannath C
    J Leukoc Biol; 2007 Oct; 82(4):956-67. PubMed ID: 17675563
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of mouse and human autophagy proteins in IFN-γ-induced cell-autonomous responses against Toxoplasma gondii.
    Ohshima J; Lee Y; Sasai M; Saitoh T; Su Ma J; Kamiyama N; Matsuura Y; Pann-Ghill S; Hayashi M; Ebisu S; Takeda K; Akira S; Yamamoto M
    J Immunol; 2014 Apr; 192(7):3328-35. PubMed ID: 24563254
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oncogene addiction and immunity: clinical implications of tumour infiltrating lymphocytes in breast cancers overexpressing the HER2/neu oncogene.
    Savas P; Caramia F; Teo ZL; Loi S
    Curr Opin Oncol; 2014 Nov; 26(6):562-7. PubMed ID: 25188474
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.